IDBS, a UK provider of data management software to many industries, including life sciences, is to acquire InforSense, a company providing scientific and business intelligence (BI) technologies, for cash. The acquisition will be completed in July.
With the addition of the InforSense products, IDBS will broaden its life sciences portfolio in the emerging areas of biomarker development and personalised medicine. The InforSense brand, its products and partnerships will continue to be developed, marketed and supported worldwide.
InforSense, a private company with offices in London (UK), Boston (US) and Shanghai (China), was founded in 1999 to develop pioneering technology in the fields of high performance computing, and large scale data mining, originally developed at Imperial College, London.
The company's core expertise is in high performance business and scientific intelligence and in web-based reporting applications that offer high capacity, rapid implementation and configurability.
InforSense has also developed applications to integrate genomics, biomarker and clinical data that provide a unique offering to researchers in the developing areas of translational and personalised medicine. The company's founder, Professor Yike Guo, will take up the role of chief innovation officer at IDBS.
Neil Kipling, ceo and founder of IDBS said: "This is a major enabling step towards becoming the number one informatics partner of r&d worldwide. An additional facet of this acquisition is the opportunity to cement a strategic informatics research relationship with Imperial College, London."